BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
1 clinical trials · Condition
◉ Watch BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study (NCT04091204) | National Cancer Institute, Naples | 2019-07-04 |
Track BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.